GPCR/G protein

All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-   B6607 (S)-(+)-Niguldipine hydrochlorideSummary: L-type Ca2+ channel blocker and α1A-adrenoceptor antagonist B6607 (S)-(+)-Niguldipine hydrochlorideSummary: L-type Ca2+ channel blocker and α1A-adrenoceptor antagonist
-   B6423 RS 23597-190 hydrochlorideSummary: 5-HT4 receptor antagonist B6423 RS 23597-190 hydrochlorideSummary: 5-HT4 receptor antagonist
-   B6596 Procaterol hydrochlorideSummary: β2 agonist B6596 Procaterol hydrochlorideSummary: β2 agonist
-   B6399 3-AQCSummary: 5-HT3 antagonist B6399 3-AQCSummary: 5-HT3 antagonist
-   B6571 A 61603 hydrobromideSummary: α-adrenoceptor agonist B6571 A 61603 hydrobromideSummary: α-adrenoceptor agonist
-   B6389 MDL 72222Summary: 5-HT3 antagonist B6389 MDL 72222Summary: 5-HT3 antagonist
-   B6570 Zinterol hydrochlorideSummary: β2-adrenoceptor agonist B6570 Zinterol hydrochlorideSummary: β2-adrenoceptor agonist
-   B6383 Quipazine dimaleateSummary: 5-HT3 receptor agonist B6383 Quipazine dimaleateSummary: 5-HT3 receptor agonist
-   B6552 CGP 20712 dihydrochlorideTarget: adrenoceptorSummary: β1 antagonist,highly potent and selective B6552 CGP 20712 dihydrochlorideTarget: adrenoceptorSummary: β1 antagonist,highly potent and selective
-   B6365 MetergolineSummary: 5-HT1/5-HT2 antagonist B6365 MetergolineSummary: 5-HT1/5-HT2 antagonist
